Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
San Diego, California, United States 5001-10000 Accelerator Early Stage Venture, Late Stage Venture www.illumina.com 2,778
Industries BiotechnologyGeneticsHealth CareMedicalHeadquarters Regions Greater San Diego Area, West Coast, Western US Founded Date 1998 Founders David R. Walt, John Stuelpnagel, Larry Bock, Satnam Alag Operating Status Active Last Funding Type Venture - Series Unknown Legal Name Illumina, Inc. Related Hubs Illumina Alumni Founded Companies
Investor Type Accelerator Investment Stage Early Stage Venture, Late Stage Venture Number of Exits 6
Stock Symbol NASDAQ:ILMN Company Type For Profit
Contact Email info@illumina.com Phone Number 858.202.4500
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission-critical to have solutions that are not only innovative, but flexible, scalable, and
complete with industry-leading support and service. As a company that places a high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, they strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
David R. Walt, Satnam Alag, Larry Bock, and John Stuelpnagel co-founded Illumina in San Diego, California in 1998.
Stock Symbol NASDAQ:ILMN Money Raised at IPO $96M IPO Share Price $16.00 IPO Date Aug 1, 2000
- Illumina Ventures
Investment Arm - Illumina Accelerator
Investment Arm
